Cargando…

Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2)

BACKGROUND: This study is designed to provide detailed knowledge on cognitive impairment after out-of-hospital cardiac arrest (OHCA) and its relation to associated factors, and to validate the neurocognitive screening of the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Car...

Descripción completa

Detalles Bibliográficos
Autores principales: Blennow Nordström, Erik, Lilja, Gisela, Vestberg, Susanna, Ullén, Susann, Friberg, Hans, Nielsen, Niklas, Heimburg, Katarina, Evald, Lars, Mion, Marco, Segerström, Magnus, Grejs, Anders M., Keeble, Thomas, Kirkegaard, Hans, Ljung, Hanna, Rose, Sofia, Wise, Matthew P., Rylander, Christian, Undén, Johan, Cronberg, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542852/
https://www.ncbi.nlm.nih.gov/pubmed/33028221
http://dx.doi.org/10.1186/s12872-020-01721-9
_version_ 1783591619985932288
author Blennow Nordström, Erik
Lilja, Gisela
Vestberg, Susanna
Ullén, Susann
Friberg, Hans
Nielsen, Niklas
Heimburg, Katarina
Evald, Lars
Mion, Marco
Segerström, Magnus
Grejs, Anders M.
Keeble, Thomas
Kirkegaard, Hans
Ljung, Hanna
Rose, Sofia
Wise, Matthew P.
Rylander, Christian
Undén, Johan
Cronberg, Tobias
author_facet Blennow Nordström, Erik
Lilja, Gisela
Vestberg, Susanna
Ullén, Susann
Friberg, Hans
Nielsen, Niklas
Heimburg, Katarina
Evald, Lars
Mion, Marco
Segerström, Magnus
Grejs, Anders M.
Keeble, Thomas
Kirkegaard, Hans
Ljung, Hanna
Rose, Sofia
Wise, Matthew P.
Rylander, Christian
Undén, Johan
Cronberg, Tobias
author_sort Blennow Nordström, Erik
collection PubMed
description BACKGROUND: This study is designed to provide detailed knowledge on cognitive impairment after out-of-hospital cardiac arrest (OHCA) and its relation to associated factors, and to validate the neurocognitive screening of the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest trial (TTM2-trial), assessing effectiveness of targeted temperature management after OHCA. METHODS: This longitudinal multi-center clinical study is a sub-study of the TTM2-trial, in which a comprehensive neuropsychological examination is performed in addition to the main TTM2-trial neurocognitive screening. Approximately 7 and 24 months after OHCA, survivors at selected study sites are invited to a standardized assessment, including performance-based tests of cognition and questionnaires of emotional problems, fatigue, executive function and insomnia. At 1:1 ratio, a matched control group from a cohort of acute myocardial infarction (MI) patients is recruited to perform the same assessment. We aim to include 100 patients per group. Potential differences between the OHCA patients and the MI controls at 7 and 24 months will be analyzed with a linear regression, using composite z-scores per cognitive domain (verbal, visual/constructive, working memory, episodic memory, processing speed, executive functions) as primary outcome measures. Results from OHCA survivors on the main TTM2-trial neurocognitive screening battery will be compared with neuropsychological test results at 7 months, using sensitivity and specificity analyses. DISCUSSION: In this study we collect detailed information on cognitive impairment after OHCA and compare this to a control group of patients with acute MI. The validation of the TTM2 neurocognitive screening battery could justify its inclusion in routine follow-up. Our results may have a potential to impact on the design of future follow-up strategies and interventions after OHCA. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03543371. Registered 1 June 2018
format Online
Article
Text
id pubmed-7542852
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75428522020-10-13 Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2) Blennow Nordström, Erik Lilja, Gisela Vestberg, Susanna Ullén, Susann Friberg, Hans Nielsen, Niklas Heimburg, Katarina Evald, Lars Mion, Marco Segerström, Magnus Grejs, Anders M. Keeble, Thomas Kirkegaard, Hans Ljung, Hanna Rose, Sofia Wise, Matthew P. Rylander, Christian Undén, Johan Cronberg, Tobias BMC Cardiovasc Disord Study Protocol BACKGROUND: This study is designed to provide detailed knowledge on cognitive impairment after out-of-hospital cardiac arrest (OHCA) and its relation to associated factors, and to validate the neurocognitive screening of the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest trial (TTM2-trial), assessing effectiveness of targeted temperature management after OHCA. METHODS: This longitudinal multi-center clinical study is a sub-study of the TTM2-trial, in which a comprehensive neuropsychological examination is performed in addition to the main TTM2-trial neurocognitive screening. Approximately 7 and 24 months after OHCA, survivors at selected study sites are invited to a standardized assessment, including performance-based tests of cognition and questionnaires of emotional problems, fatigue, executive function and insomnia. At 1:1 ratio, a matched control group from a cohort of acute myocardial infarction (MI) patients is recruited to perform the same assessment. We aim to include 100 patients per group. Potential differences between the OHCA patients and the MI controls at 7 and 24 months will be analyzed with a linear regression, using composite z-scores per cognitive domain (verbal, visual/constructive, working memory, episodic memory, processing speed, executive functions) as primary outcome measures. Results from OHCA survivors on the main TTM2-trial neurocognitive screening battery will be compared with neuropsychological test results at 7 months, using sensitivity and specificity analyses. DISCUSSION: In this study we collect detailed information on cognitive impairment after OHCA and compare this to a control group of patients with acute MI. The validation of the TTM2 neurocognitive screening battery could justify its inclusion in routine follow-up. Our results may have a potential to impact on the design of future follow-up strategies and interventions after OHCA. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03543371. Registered 1 June 2018 BioMed Central 2020-10-07 /pmc/articles/PMC7542852/ /pubmed/33028221 http://dx.doi.org/10.1186/s12872-020-01721-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Blennow Nordström, Erik
Lilja, Gisela
Vestberg, Susanna
Ullén, Susann
Friberg, Hans
Nielsen, Niklas
Heimburg, Katarina
Evald, Lars
Mion, Marco
Segerström, Magnus
Grejs, Anders M.
Keeble, Thomas
Kirkegaard, Hans
Ljung, Hanna
Rose, Sofia
Wise, Matthew P.
Rylander, Christian
Undén, Johan
Cronberg, Tobias
Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2)
title Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2)
title_full Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2)
title_fullStr Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2)
title_full_unstemmed Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2)
title_short Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2)
title_sort neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (ttm2)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542852/
https://www.ncbi.nlm.nih.gov/pubmed/33028221
http://dx.doi.org/10.1186/s12872-020-01721-9
work_keys_str_mv AT blennownordstromerik neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT liljagisela neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT vestbergsusanna neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT ullensusann neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT friberghans neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT nielsenniklas neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT heimburgkatarina neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT evaldlars neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT mionmarco neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT segerstrommagnus neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT grejsandersm neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT keeblethomas neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT kirkegaardhans neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT ljunghanna neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT rosesofia neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT wisematthewp neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT rylanderchristian neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT undenjohan neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2
AT cronbergtobias neuropsychologicaloutcomeaftercardiacarrestaprospectivecasecontrolsubstudyofthetargetedhypothermiaversustargetednormothermiaafteroutofhospitalcardiacarresttrialttm2